HHS allocates over $4B in relief to hospitals hit hard by the pandemic

The U.S. Department of Health and Human Services is releasing nearly $3 billion in funds from the CARES Act for safety-net hospitals serving regions hit hard by the pandemic.

HHS Secretary Alex Azar said he expects to distribute $3 billion in funding across 215 acute care facilities, placing the total payments for safety-net hospitals from the Provider Relief Fund at $12.8 billion, spread across 959 institutions.

"We've been distributing the Provider Relief Funds as quickly as possible to those providers who have been hardest hit by the pandemic," Azar said in a Friday statement.  "President Trump is supporting hospitals in continuing to provide COVID-19 care and returning to everyday procedures, especially hospitals that serve vulnerable and minority populations.”

Another $1 billion is going toward specialty rural hospitals, urban hospitals with certain rural Medicare designations and providers in small metropolitan areas, according to the announcement. The funds should help offer relief to nearly 500 hospitals, HHS estimates.

Rural-designated providers will receive payments ranging from $100,000 to $4.5 million, while other hospitals are set to receive funding from $100,000 to $2 million.

HHS also announced that dentists are now able to apply for relief. It did not reveal the total amount set aside for such practices.

The CARES Act allocated $175 billion in relief funds to hospitals and healthcare providers. An estimated $115 billion of that total has now been handed out.

Some large healthcare companies that received funding announced they will return some or all of the pandemic-related relief, including CVS Health, Kaiser Permanente, Encompass, DaVita and more.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.